Smoking and Cancer

Cigarette Smoke Toxicity: Linking Individual Chemicals to Human Diseases

Volumn , Issue , 2011, Pages 145-166

  Chowdhury, Parimal ^a   MacLeod, Stewart ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Benzopyrene; Carcinogen biomarkers; DNA repair; Lung cancer; Neoplasia; Nicotinic acetylcholine receptor A; Nicotinic cholinergic receptors; NNK; NNN; PAHs; Squamous cell carcinoma

Indexed keywords

EID: 84882930213     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527635320.ch8     Document Type: Chapter

References (130)

1. Mackay, J. and Erikson, M. (2002) The Tobacco Atlas, World Health Organization, Geneva, pp. 24-27.
2. Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Department of Heath and Human Services. Smoking and Tobacco Use-Fact Sheet: Health Effects of Cigarette Smoking. Updated January 2008 Available at: http://www.cdc.gov/ tobacco/data_statistics/fact_sheets/ health_effects/effects_cig_smoking/ index.htm.
3. Ries, L.A.G., Eisner, M.P., Kosary, C.L., et al. (2004) SEER Cancer Statistics Review, 1975-2001, National Cancer Institute, Bethesda, MD.
4. International Agency for Research on Cancer (2004) Tobacco smoke and involuntary smoking, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 83, IARC, Lyon, France, pp. 1179-1187.
5. Centers for Disease Control and Prevention. Tobacco Use in the United States. http://www.cdc.gov/tobacco/ overview/tobus_us.htm (accessed 30 September 2003).
6. International Agency for Research on Cancer (1986) Tobacco Smoke and Involuntary Smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 38, IARC, Lyon, France, pp. 37-375.
7. Straif, K., Baan, R., Grosse, Y., Secretan, B., El Ghissassi, F., and Coglianao, V. (2005) Carcinogenicity of polycyclic aromatic hydrocarbons. Lancet Oncol., 6, 931-932.
8. Hecht, S.S. (1998) Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol., 11, 559-603.
9. Hecht, S.S. and Hoffmann, D. (1988) Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis, 9, 875-884.
10. International Agency for Research on Cancer (2006) Smokeless Tobacco And Tobacco-Specific Nitrosamines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 89, IARC, Lyon, France.
11. Preussmann, R. and Stewart, B.W. (1984) N-nitroso carcinogens, in Chemical Carcinogens, 2nd edn, ACS monograph 182, vol. 2 (ed. C.E. Searle), American Chemical Society, Washington, DC, pp. 643-828.
12. Hoffmann, D. and Hoffmann, I. (1997) The changing cigarette, 1950-1995. J. Toxicol. Environ. Health, 50, 307-364.
13. Hoffmann, D., Brunnmann, K.D., Propkopczyk, B., and Djordjevic, M.V. (1994) Tobacco specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J. Toxicol. Environ. Health, 41, 1-52.
14. Hecht, S.S. (2003) Tobacco carcinogens, their biomarkers and tobacco induced cancer. Nat. Rev. Cancer, 3, 733-745.
15. Minna, J.D., Roth, J.A., and Gazdar, A. (2002) Focus on lung cancer. Cancer Cell, 1, 49-62.
16. Wistuba, I.I. (2007) Genetics of preneoplasia: lessons from lung cancer. Curr. Mol. Med., 7, 1-12.
17. Kerr, K.M. (2001) Pulmonary preinvasive neoplasia. J. Clin. Pathol., 54 (4), 257-271.
18. Ahrendt, S.A., Decker, P.A., Alawi, E.A., Zhyyr, Y.R., Sachez-Cespedes, M., Yang, S.C., Haaster, G.B., Kajdacsy -Balla, A., Demeure, M.J., and Sidransky, D. (2001) Cigarette smoking is strongly associated with mutation of the k-ras gene in patients with primary adenocarcinoma of the lung. Cancer, 92 (6), 1525-1530. 160 8 Smoking and Cancer
19. Rodenhuis, S. and Siebos, R.J. (1992) Clinical significance of ras oncogene activation in human lung cancer. Cancer Res., 52 (9), 2665s-2669s.
20. Ahrendt, S.A., Chow, J.T., Yang, S.C., Wu, L., Zhang, M.J., Jen, J., and Sidranasky, D. (2000) Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer. Cancer Res., 60 (12), 3155-3159.
21. Pfeffer, G.P., Denissenko, M.F., Olivier M. Tretyakova, N., Hecht, S.S., and Hainaut, P. (2002) Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking associated cancers. Oncogene, 21 (48), 7435-7451.
22. Hainaut, P. and Pfeffer, G.P. (2001) Patterns of G---> T transversions in lung cancers reflect the primary mutagenic signature of DNA damage by tobacco smoke. Carcinogenesis, 22 (3), 367-374.
23. Pfeffer, G.P. and Hainaut, P. (2003) On the origin of G---> T transversions in lung cancer. Mutat. Res., 526 (1-2), 39-43.
24. Cox, L.A. and Sanders, E. (2006) Estimating preventable fractions of disease caused by a specified biological mechanism: PAHs in smoking lung cancers as an example. Risk Anal., 26 (4), 881-892.
25. Lubin, J.H. and Caporaso, N.E. (2006) Cigarette smoking and lung cancer: modeling total exposure and intensity. Cancer Epidemiol. Biomarkers Prev., 15 (3), 517-523.
26. Hecht, S.S. (2006) Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbecks Arch. Surg., 391, 603-613.
27. Lowenfels, A.B. (1984) Chronic pancreatitis, pancreatic cancer, alcohol, and smoking. Gastroenterology, 87 (3), 744-745.
28. Morabia, A. and Wynder, E.L. (1991) Cigarette smoking and lung cancer cell types. Cancer, 68, 2074-2078.
29. Sridhar, K.S. and Raub, W.A. Jr (1992) Present and past smoking history and other predisposing factors in 100 lung cancer patients. Chest, 101, 19-25.
30. Ahmed, S. and Billimek, J. (2007) Limiting youth access to tobacco: Comparing the long-term health impacts of increasing cigarette excise taxes and raising the legal smoking age to 21 in the United States. Health Policy, 80 (3), 378-391.
31. U.S. Department of Health and Human Services (1989) Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General, DHHS Publ. No. (CDC) 89-8411, U.S. Department of Health and Human Services, Centers for Disease Control, Centers for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health, Rockville, MD.
32. Burns, D.M. (1991) The scientific rationale for comprehensive community-based smoking control strategies, in Strategies to Control Tobacco Use in the United States-A Blueprint for Public Health Action in the 1990 ' s Smoking and Tobacco Control Monograph No 1, vol. 16, NIH Publ. No. 92-33, U.S. Department of Health and Human Services, Public Health Service, National Institute of Health, National Cancer Institute, Bethesda, MD, pp. 75-144.
33. Pechacek, T.F., Asama, S., and Erikson, M.P. (1998) Tobacco global burden and community solutions, in Evidence Based Cardiology (eds S. Yusuf, J.A. Cairns, A.J. Camm, E.L. Falen, and B.J. Gersh), BMJ Books, London, pp. P165-P178.
34. Satcher, D. and Erikson, M. (1994) The paradox of tobacco control [editorial]. JAMA, 271, 627-628.
35. U.S. Department of Health and Human Services (1996) Smoking Cessation, Clinical Practice Guideline No. 18. U.S. Department of Health and Human Services, Public Health Service Agency for Health Care Policy and Research, Washington, DC, DHHHS Publ. No. (AHCPR) 96-0692.
36. Wynder, E.L. and Muscat, J.E. (1995) The changing epidemiology of smoking and lung cancer histology. Environ. Health Perspect., 103 (Suppl 8), 143-148.
37. Djordjevic, M.V., Stellman, S.D., and Zang, E. (2000) Doses of nicotine and lung carcinogens delivered to cigarette References 161 smokers. J. Natl. Cancer Inst., 92 (2), 106-111.
38. Benowitz, N.L., Hall, S.M., Stewart, S., Wilson, M., Dempsey, D., and Jacob, P. (2007) Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette. Cancer Epidemiol. Biomarkers Prev., 16, 2479-2485.
39. American Cancer Society (2004) Cancer Facts and Figures 2004, American Cancer Society, Atlanta, GA
40. World Cancer Research Fund (1997) American Institute for Cancer Research. Food Nutrition and the Prevention of Cancer: A Global Perspective, American Institute of Cancer Research, Washington, DC, pp. 37-145.
41. Wynder, E.L. and Graham, E.A. (1950) Tobacco smoking as a possible etiologic factor in bronchogenic carcinoma. A study of six hundred and eighty four proved cases. JAMA, 143, 329-336.
42. Doll, R. and Hill, A.B. (1950) Smoking and carcinoma of the lung. A preliminary report. BMJ, ii, 730-748.
43. Wei, Q., Cheng, L., Amos, C.I., Wang, L.E., Guo, Z., Hong, W.K., and Spitz, M.R. (2000) Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J. Natl. Cancer Inst., 92 (21), 1764-1772.
44. Derby, K.S., Cuthrell, K., Caberto, C., Carmella, S.G., Franke, A.A., Hecht, S.S., Murphy, S.E., and Le Marchand, L. (2008) Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer. Cancer Epidemiol. Biomarkers Prev., 17 (12), 3526-3535.
45. Le Marchand, L., Derby, K.S., Murphy, S.E., Hecht, S.S., Hatsukami, D., Carmella, S.G., Tirikainen, M., and Wang, H. (2008) Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamines. Cancer Res., 68 (22), 9137-9140.
46. Doll, R. and Hill, A.B. (1952) A study of the aetiology of carcinoma of the lung. BMJ, 2, 1271-1286.
47. Hammond, E.C. and Horn, D. (1958) Smoking and Death rates: Report of forty four months of follow-up of 187,783 men. JAMA, 166, 1159-1172, 1294-1308.
48. Auerbach, O., Stout, A.P., Hammond, E.C., and Garfinkle, L. (1961) Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N. Engl. J. Med., 265, 253-267.
49. Hammond, E.C., Auebach, O., Kirman, D., and Garfinkle, L. (1970) Effects of cigarette smoking on dogs. Arch. Environ. Health, 21, 740-768.
50. Franlin, W., Wistuba, I., Geisinger, K., Lam, S., Hirsch, F., Muller, K.M., Sozzi, G., Brambilla, E., and Gazdar, A. (2004) Pathology and genetics, in Tumors of the Lung, Pleura, Thymus, and Heart: World Health Organization Classification of Tumours (eds W. Travis, E. Brambilla, H.K. Muller-Hermelink, and C.C. Harris), IARC, Lyon, pp. 68-72.
51. Wistuba, I.I., Mao, L., and Gazdar, A.F. (2002) Smoking molecular damage in bronchial epithelium. Oncogene, 21, 7298-7306.
52. International Agency for Research on Cancer (2006) Biennial Report (2004-2005), IARC, Lyon
53. Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R.C., Ghafoor, A., Feuer, E.J., and Thun, M.J. (2005) Cancer statistics, 2005. CA Cancer J. Clin., 55, 10-30.
54. Lubin, J.H. and Blot, W.J. (1993) Lung cancer and smoking cessation: patterns of risk. J. Natl. Cancer Inst., 85, 422-423.
55. Tong, L., Spitz, M.R., Fuegar, J.J., and Amos, C.A. (1996) Lung carcinoma in former smokers. Cancer, 78, 1004-1010.
56. Lam, S., leRiche, J.C., Zhang, Y., Coldman, A., MacAulay, C., Hawk, E., Kelloff, G., and Gazdar, A.F. (1999) Sex-related differences in bronchial epithelial changes associated with tobacco smoking. J. Natl. Cancer Inst., 91, 691-696.
57. International Agency for Research on Cancer (2002) Tobacco Smoke and Involuntary Smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 83, IARC, Lyon, France, pp. 1179-1187.
58. Centers for Disease Control (2005) Cigarette smoking among adults-United States, 2004. MMWR, 54, 1121-1124.
59. Hecht, S.S. (2002) Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis, 23, 907-922.
60. Hecht, S.S. (1999) Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst., 91, 1194-1210.
61. Hecht, S.S. (2002) Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol., 3, 461-469.
62. U.S. Department of health and Human Services (1988) N icotine Addiction: A Report of the Surgeon General. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Centers for Health Promotion and Education, Office of Smoking and Health, Rockville, MD.
63. Dennis, P.A., Van Waes, C., Gutkind, J.S., Kellar, K.J., Vinson, C., Mukhin, A.G., Spitz, M.R., Bailey-Wilson, J.E., Yeh, G.C., Anderson, L.M., and Wiest, J.S. (2005) The biology of tobacco and nicotine: bench to bedside. Cancer Epidemiol. Biomarkers Prev., 4 (4), 764-767.
64. Kleinsasser, N.H., Sassen, A.W., Semmler, M.P., Staudenmaier, R., Harreus, U.A., and Richter, E. (2006) Does nicotine add to the carcinogenic strain of tobacco smoke? HNO, 54 (5), 369-372, 374-375.
65. Lawrence, D. (2005) Nicotine may promote tumour growth, US researchers suggest. Lancet, 361 (9352), 146.
66. West, K.A., Brongnard, J., Clark, A.S., Linnoila, H.R., Yang, X., Swain, S.M., Harris, C., Belinsky, S., and Dennis, P.A. (2003) Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J. Clin. Invest., 111 (1), 81-90.
67. Rivensen, A., Hoffman, D., Prokopczyk, B., Amin, S., and Hecht, S.S. (1988) Induction of lung and exocrine pancreatic tumours in F-344 rats by tobacco specific areca derived nitrosamines. C ancer Res., 48, 6912-6017.
68. Pfeeifer, G.P., Denissenko, M.F., Olivier, M., Tretyakova, N., Hecht, S.S., and Hainaut, P. (2002) Tobacco smoke carcinogens, DNA damage, and p-53 mutations in smoke associated cancers. Oncogene, 21, 7435-7451.
69. Heusch, W.J. and Manecckjee, R. (1998) Signaling pathways involved in nicotine regulation of apoptosis of human lung cancer cells. Carcinogenesis, 19, 551-556.
70. West, K.A., Brongnard, J., Clark, A.S., Linnoila, H.R., Yang, X., Swain, S.M., Harris, C., Belinsky, S., and Dennis, P.A. (2003) Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J. Clin. Invest., 111 (1), 81-90.
71. Lawler, M.A. and Alessi, D.R. (2001) Akt: a key mediator of cell proliferation, survival and insulin responses? J. Cell Sci., 114, 2903-2910.
72. Scheid, M.P. and Woodgett, J.R. (2001) Pkb/akt: functional insights from genetic models. Nat. Rev. Mol. Cell Biol., 2, 760-768.
73. Dasgupta, P., Rizwani, W., Pillai, S., Kinkade, R., Kovacs, M., Rastogi, S., Banerjee, S., Carless M., Kim, E., Coppola, D., Haura, E., and Chellapan, S. (2009) Nicotine induces cell proliferation, invasion and epithelial -mesenchymal transition (EMT) in a variety of human cancer cell lines. Int. J. Cancer, 124 (1), 36-45.
74. Novak, J., Escobedo-Morse, A., Kelley, K., Boose, D., Kautzman-Eades, D., Mayer, M., and Kane, M.A. (2000) Nicotine effects on proliferation and the bombesin-like peptide autocrine system in human small cell lung carcinoma SHP77 cells in culture. Lung Cancer, 29 (1), 1-10.
75. Schuler, H.M. (2007) Nitrosamines as nicotinic receptor ligands. Life Sci., 80 (24-25), 2274-2280.
76. Arredondo, J., Chernyavsky, A.I., and Grando, S.A. (2006) Nicotinic receptors mediate tumorigenic action of tobacco-derived nitrosamines on immortalized oral epithelial References 163 cells. Cancer Biol. Ther., 5 (5), 511-517.
77. Zhang, Q., Tang, X., Zhang, Z.F., Velikina, R., Shi, S., and Le, A.D. (2007) Hypoxia-inducible factor-1 alpha expression in human lung cancer cells via nicotinic acetylcholine receptor -mediated signalling pathways. Clin. Cancer Res., 13 (16), 4686-4694.
78. Peto, R., Lopez, A.D., Boreham, J., Thun, M., and Heath, C., Jr (1992) Mortality from tobacco in developed. countries: indirect estimation from national vital statistics. Lancet, 339 (8804), 1268-1278.
79. Maisonneuve, P. and Lowenfels, A.B. (2002) Chronic pancreatitis and pancreatic cancer. Dig. Dis., 20 (1), 32-37.
80. Mulder, I., van Genugten, M.L., Hoogenveen, R.T., de Hollander, A.E., and Bueno-de-Mesquita, H.B. (1999) The impact of smoking on future pancreatic cancer: a computer simulation. Ann. Oncol., 10 (Suppl 4), 74-78.
81. Mulder, I., Hoogenveen, R.T., van Genugten, M.L., Lankisch, P.G., Lowenfels, A.B., de Hollander, A.E., and Bueno-de-Mesquita, H.B. (2002) Smoking cessation would substantially reduce the future incidence of pancreatic cancer in the European Union. Eur. J. Gastroenterol. Hepatol., 14 (12), 1343-1353.
82. Lowenfels, A.B. and Maisonneuve, P. (2004) Epidemiology and prevention of pancreatic cancer. Jpn. J. Clin. Oncol., 34 (5), 238-244.
83. Lowenfels, A.B. and Maisonneuve, P. (2005) Risk factors for pancreatic cancer. J. Cell. Biochem., 95 (4), 649-656.
84. Talamani, G., Falconi, M., Bassi, C., et al. (1999) Incidence of cancer in the course of chronic pancreatitis. Am. J. Gastroenterol., 94 (5), 1253-1260.
85. Talamini, G., Bassi, C., Falconi, M., et al. (1999) Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Dig. Dis. Sci., 44 (7), 1303-1311.
86. Doll, R., Peto, R., Wheatley, K., Gray, R., and Sutherland, I. (1994) Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ, 309 (6959), 901-911.
87. Fuchs, C.S., Colditz, G.A., Stampfer, M.J., Giovannucci, E.L., Hunter, D.J., Rimm, E.B., Willett, W.C., and Speizer, F.E. (1996) A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch. Intern. Med., 156 (19), 2255-2260.
88. Lynch, S.M., Vrieling, A., Lubin, J.H., Kraft, P., Mendelsohn, J.B., Hartge, P., Canzian, F., Steplowski, E., Arslan, A.A., Gross, M., Helzlsouer, K., Jacobs, E.J., LaCroix, A., Petersen, G., Zheng, W., Albanes, D., Amundadottir, L., Bingham, S.A., Boffetta, P., Boutron -Ruault, M.C., Chanock, S.J., Clipp, S., Hoover, R.N., Jacobs, K., Johnson, K.C., Kooperberg, C., Luo, J., Messina, C., Palli, D., Patel, A.V., Riboli, E., Shu, X.O., Rodriguez Suarez, L., Thomas, G., Tjonneland, A., Tobias, G.S., Tong, E., Trichopoulos, D., Virtamo, J., Ye, W., Yu, K., Zeleniuch-Jacquette, A., Bueno-de-Mesquita, H.B., and Stolzenberg-Solomon, R.Z. (2009) Cigarette smoking and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium. Am. J. Epidemiol., 170 (4), 403-413.
89. Hassan, M.M., Abbruzzese, J.L., Bondy, M.L., Wolff, R.A., Vauthey, J.N., Pisters, P.W., Evans, D.B., Khan, R., Lenzi, R., Jiao, L., and Li, D. (2007) Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study. Cancer, 109 (12), 2547-2556.
90. Bueno de Mesquita, H.B., Maisonneuve, P., Moerman, C.J., Runia, S., and Boyle, P. (1991) Life-time history of smoking and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands. Int. J. Cancer, 49 (6), 816-822.
91. Farrow, D.C. and Davis, S. (1990) Risk of pancreatic cancer in relation to medical history and the use of tobacco, alcohol and coffee. Int. J. Cancer, 45 (5), 816-820.
92. Fernandez, E., La, V.C., Porta, M., et al. (1995) Pancreatitis and the risk of pancreatic cancer. Pancreas, 11 (2), 185-189.
93. Gold, E.B. and Goldin, S.B. (1998) Epidemiology of and risk factors for pancreatic cancer. Surg. Oncol. Clin. N. Am., 7 (1), 67-91.
94. Howe, G.R., Jain, M., Burch, J.D., and Miller, A.B. (1991) Cigarette smoking and cancer of the pancreas: evidence from a population-based case-control study in Toronto, Canada. Int. J. Cancer, 47 (3), 323-328.
95. Olsen, G.W., Mandel, J.S., Gibson, R.W., Wattenberg, L.W., and Schuman, L.M. (1989) A case-control study of pancreatic cancer and cigarettes, alcohol, coffee and diet. Am. J. Public Health, 79 (8), 1016-1019.
96. Silverman, D.T. (2001) Risk factors for pancreatic cancer: a case-control study based on direct interviews. Teratog. Carcinog. Mutagen., 21 (1), 7-25.
97. Wynder, E.L., Mabuchi, K., Maruchi, N., and Fortner, J.G. (1973) Epidemiology of cancer of the pancreas. J. Natl. Cancer Inst., 50 (3), 645-667.
98. Silverman, D.T., Dunn, J.A., Hoover, R.N., Schiffman, M., Lillemoe, K.D., Schoenberg, J.B., Brown, L.M., Greenberg, R.S., Hayes, R.B., and Swanson, G.M. (1994) Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J. Natl. Cancer Inst., 86 (20), 1510-1516.
99. Mack, T.M., Yu, M.C., Hanisch, R., and Henderson, B.E. (1986) Pancreas cancer and smoking, beverage consumption, and past medical history. J. Natl. Cancer Inst., 76 (1), 49-60.
100. Wittel, U.A., Hopt, U.T., and Batra, S.K. (2008) Cigarette smoke-induced pancreatic damage: experimental data. Langenbecks Arch. Surg., 393 (4), 581-588.
101. Wittel, U.A., Pandey, K.K., Andrianifahanana, M., Johansson, S.L., Cullen, D.M., Akhter, M.P., Brand, R.E., Prokopczyk, B., and Batra, S.K. (2006) Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. Am. J. Gastroenterol., 101 (1), 148-159.
102. Chowdhury, P., Bose, C., and Udupa, K.B. (2007) Nicotine-induced proliferation of isolated rat pancreatic acinar cells: effect on cell signalling and function. C ell Prolif., 40 (1), 125-141.
103. Chowdhury, P. and Walker, A. (2008) A cell-based approach to study changes in the pancreas following nicotine exposure in an animal model of injury. Langenbecks Arch. Surg., 393 (4), 547-555.
104. Brown, P. (1976) The influence of smoking on pancreatic function in man. Med. J. Aust., 2 (8), 290-293.
105. Milnerowicz, H., Sliwinska, M., Jablonowska, M., and Milnerowicz, S. (2004) Effect of tobacco smoking on amylase activity in patients with pancreatitis. P rzegl. Lek., 61 (10), 1071-1072.
106. Tai, M.H., Upham, B.L., Olson, L.K., Tsao, M.S., Reed, D.N., Jr, and Trosko, J.E. (2007) Cigarette smoke components inhibited intercellular communication and differentiation in human pancreatic ductal epithelial cells. Int. J. Cancer, 120 (9), 1855-1862.
107. Pour, P.M., Salmasi, S.Z., and Runge, R.G. (1978) Selective induction of pancreatic ductular tumors by single doses of N-nitrosobis(2-oxopropyl)amine in Syrian golden hamsters. Cancer Lett., 4 (6), 317-323.
108. Prokopczyk, B., Hoffmann, D., Bologna, M., Cunningham, A.J., Trushin, N., Akerkar, S., Boyiri, T., Amin, S., Desai, D., Colosimo, S., Pittman, B., Leder, G., Ramadani, M., Henne-Bruns, D., Beger, H.G., and El-Bayoumy, K. (2002) Identification of tobacco-derived compounds in human pancreatic juice. Chem. Res. Toxicol., 15 (5), 677-685.
109. Phillips, D.H. (2002) Smoking-related DNA and protein adducts in human tissues. Carcinogenesis, 23 (12), 1979-2004.
110. Schuller, H.M. (2002) Mechanisms of smoking-related lung and pancreatic adenocarcinoma development. Nat. Rev. Cancer, 2 (6), 455-463.
111. Hecht, S.S. (1996) Recent studies on mechanisms of bioactivation and References 165 detoxification of 4-(methylnitrosamino) -1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen. Crit. Rev. Toxicol., 26 (2), 163-181.
112. Schuller, H.M., Tithof, P.K., Williams, M., and Plummer, H., III (1999) The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1 -butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. Cancer Res., 59 (18), 4510-4515.
113. Weddle, D.L., Tithoff, P., Williams, M., and Schuller, H.M. (2001) Beta -adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas. Carcinogenesis, 22 (3), 473-479.
114. Askari, M.D., Tsao, M.S., and Schuller, H.M. (2005) The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3 -pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through beta-adrenergic transactivation of EGF receptors. J. Cancer Res. Clin. Oncol., 131 (10), 639-648.
115. Porta, M., Malats, N., Jariod, M., Grimalt, J.O., Rifa, J., Carrato, A., Guarner, L., Salas, A., Santiago-Silva, M., Corominas, J.M., Andreu, M., and Real, F.X. (1999) Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group. Lancet, 354 (9196), 2125-2129.
116. Crous-Bou, M., Porta, M., Lopez, T., Jariod, M., Malats, N., Alguacil, J., Morales, E., Fernandez, E., Corominas, J.M., Carrato, A., Guarner, L., and Real, F.X. (2007) Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer. Pancreas, 35 (2), 135-141.
117. Porta, M., Crous-Bou, M., Wark, P.A., Vineis, P., Real, F.X., Malats, N., and Kampman, E. (2009) Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: Etiopathogenic similarities, differences and paradoxes. Mutat. Res., 682 (2-3), 83-93.
118. Blackford, A., Parmigiani, G., Kensler, T.W., Wolfgang, C., Jones, S., Zhang, X., Parsons, D.W., Lin, J.C., Leary, R.J., Eshleman, J.R., Goggins, M., Jaffee, E.M., Iacobuzio-Donahue, C.A., Maitra, A., Klein, A., Cameron, J.L., Olino, K., Schulick, R., Winter, J., Vogelstein, B., Velculescu, V.E., Kinzler, K.W., and Hruban, R.H. (2009) Genetic mutations associated with cigarette smoking in pancreatic cancer. Cancer Res., 69 (8), 3681-3688.
119. Anderson, K.E., Hammons, G.J., Kadlubar, F.F., Potter, J.D., Kaderlik, K.R., Ilett, K.F., Minchin, R.F., Teitel, C.H., Chou, H.C., Martin, M.V., Guengerich, F.P., Barone, G.W., Lang, N.P., and Peterson, L.A. (1997) Metabolic activation of aromatic amines by human pancreas. Carcinogenesis, 18 (5), 1085-1092.
120. Stepanov, I., Upadhyaya, P., Carmella, S.G., Feuer, R., Jensen, J., Hatsukami, D.K., and Hecht, S.S. (2008) Extensive metabolic activation of the tobacco -specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1 -butanone in smokers. Cancer Epidemiol. Biomarkers Prev., 17 (7), 1764-1773.
121. Suzuki, H., Morris, J.S., Li, Y., Suzuki, H., Morris, J.S., Li, Y., Doll, M.A., Hein, D.W., Liu, J., Jiao, L., Hassan, M.M., Day, R.S., Bondy, M.L., Abbruzzese, J.L., and Li, D. (2008) Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer. Carcinogenesis, 29 (6), 1184-1191.
122. Duell, E.J., Holly, E.A., Bracci, P.M., Liu, M., Wiencke, J.K., and Kelsey, K.T. (2002) A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. J. Natl. Cancer Inst., 94 (4), 297-306.
123. Fujita, K. and Kamataki, T. (2001) Predicting the mutagenicity of tobacco-related N-nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 166 8 Smoking and Cancer along with NADPH-cytochrome P450 reductase. E nviron. Mol. Mutagen., 38 (4), 339-346.
124. Kamataki, T., Fujita, K., Nakayama, K., Yamazaki, Y., Miyamoto, M., and Ariyoshi, N. (2002) Role of human cytochrome P450 (CYP) in the metabolic activation of nitrosamine derivatives: application of genetically engineered Salmonella expressing human CYP. Drug Metab. Rev., 34 (3), 667-676.
125. Kadlubar, S., Anderson, J.P., Sweeney, C., Gross, M.D., Lang, N.P., Kadlubar, F.F., and Anderson, K.E. (2009) Phenotypic CYP2A6 variation and the risk of pancreatic cancer. JOP, 10 (3), 263-270.
126. Centers for Disease Control and Prevention (CDC) (2007) Cigarette smoking among adults-United States. MMWR Morb. Mortal. Wkly. Rep., 57 (45), 1221-1226.
127. Centers for Disease Control and Prevention (CDC) (1997) Cigarette smoking among adults-United States, 1995. MMWR Morb. Mortal. Wkly. Rep., 46, 1217-1220.
128. Shields, P.G. (2002) Molecular epidemiology of smoking and lung cancer. Oncogene, 21 (45), 6870-6876.
129. Shields, P.G. (1999) Molecular epidemiology of lung cancer. Anal. Oncol, 10 (Suppl 5), S7-11.
130. Wingo, P.A., Lynn, A.G., Giovino, G.A., Miller, D.S., Rosenberg, H.M., Shopland, D.R., Yhun, M.J., and Edwards, B.K. (1999) Annual report to the Nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J. Natl. Cancer Inst., 91 (8), 675-690.